I-Mab to Participate at the Truist Securities BioPharma Symposium
Press Releases
I-MAB Biopharma  
October 28, 2024

I-Mab to Participate at the Truist Securities BioPharma Symposium

ROCKVILLE, Md., Oct. 28, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a US-based, global, biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today

avatar profile Olean Times Herald

Olean Times Herald


Local & Social